
Christian C. Boesen
Examiner (ID: 11357, Phone: (571)270-1321 , Office: P/1639 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 4131, 1675, 1636, 1639, 1684 |
| Total Applications | 995 |
| Issued Applications | 677 |
| Pending Applications | 91 |
| Abandoned Applications | 262 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18739924
[patent_doc_number] => 20230348893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => NOVEL CELLULAR PHENOTYPE SCREENING METHOD
[patent_app_type] => utility
[patent_app_number] => 18/186118
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18186118
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/186118 | NOVEL CELLULAR PHENOTYPE SCREENING METHOD | Mar 16, 2023 | Pending |
Array
(
[id] => 18693049
[patent_doc_number] => 20230323435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHODS AND COMPOSITIONS FOR MAXIMUM RELEASE OF OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 18/185220
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185220
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/185220 | METHODS AND COMPOSITIONS FOR MAXIMUM RELEASE OF OLIGONUCLEOTIDES | Mar 15, 2023 | Pending |
Array
(
[id] => 18628530
[patent_doc_number] => 20230287396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHODS AND COMPOSITIONS OF NUCLEIC ACID ENRICHMENT
[patent_app_type] => utility
[patent_app_number] => 18/177415
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18177415
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/177415 | METHODS AND COMPOSITIONS OF NUCLEIC ACID ENRICHMENT | Mar 1, 2023 | Abandoned |
Array
(
[id] => 18537967
[patent_doc_number] => 20230243070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => RECOMBINANT PEPTIDE-MHC COMPLEX BINDING PROTEINS AND THEIR GENERATION AND USE
[patent_app_type] => utility
[patent_app_number] => 18/174086
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18174086
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/174086 | RECOMBINANT PEPTIDE-MHC COMPLEX BINDING PROTEINS AND THEIR GENERATION AND USE | Feb 23, 2023 | Pending |
Array
(
[id] => 19051210
[patent_doc_number] => 20240093179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SINGLE DOMAIN ANTIBODY LIBRARIES WITH MAXIMIZED ANTIBODY DEVELOPABILITY CHARACTERISTICS
[patent_app_type] => utility
[patent_app_number] => 18/171063
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 519
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18171063
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/171063 | Single domain antibody libraries with maximized antibody developability characteristics | Feb 16, 2023 | Issued |
Array
(
[id] => 18726417
[patent_doc_number] => 20230340697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR1, CDR2, AND CDR3 AND NOVEL LC CDR1, CDR2, AND CDR3 DESIGNS
[patent_app_type] => utility
[patent_app_number] => 18/160407
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160407
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160407 | LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR1, CDR2, AND CDR3 AND NOVEL LC CDR1, CDR2, AND CDR3 DESIGNS | Jan 26, 2023 | Pending |
Array
(
[id] => 19318815
[patent_doc_number] => 20240240358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => DYNAMIC HUMAN HEAVY CHAIN ANTIBODY LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 18/153070
[patent_app_country] => US
[patent_app_date] => 2023-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153070
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153070 | Dynamic human heavy chain antibody libraries | Jan 10, 2023 | Issued |
Array
(
[id] => 18628718
[patent_doc_number] => 20230287597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => DYNAMIC HUMAN ANTIBODY LIGHT CHAIN LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 18/153067
[patent_app_country] => US
[patent_app_date] => 2023-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153067
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153067 | DYNAMIC HUMAN ANTIBODY LIGHT CHAIN LIBRARIES | Jan 10, 2023 | Pending |
Array
(
[id] => 18567424
[patent_doc_number] => 20230257757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => System and Method of Modular Cloning
[patent_app_type] => utility
[patent_app_number] => 18/150272
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 565
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150272
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150272 | System and Method of Modular Cloning | Jan 4, 2023 | Abandoned |
Array
(
[id] => 18497416
[patent_doc_number] => 20230220049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => METHOD FOR PROMOTING DIVERSIFICATION OF ANTIBODY VARIABLE REGION
[patent_app_type] => utility
[patent_app_number] => 18/149439
[patent_app_country] => US
[patent_app_date] => 2023-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18149439
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/149439 | METHOD FOR PROMOTING DIVERSIFICATION OF ANTIBODY VARIABLE REGION | Jan 2, 2023 | Pending |
Array
(
[id] => 18649849
[patent_doc_number] => 20230295674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => METHOD FOR SCREENING TARGET GENE USING CRISPRI SYSTEM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/146556
[patent_app_country] => US
[patent_app_date] => 2022-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146556
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/146556 | METHOD FOR SCREENING TARGET GENE USING CRISPRI SYSTEM AND USES THEREOF | Dec 26, 2022 | Pending |
Array
(
[id] => 18903057
[patent_doc_number] => 20240018542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => CO-PACKAGING TO MITIGATE INTERMOLECULAR RECOMBINATION
[patent_app_type] => utility
[patent_app_number] => 18/067900
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18067900
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/067900 | CO-PACKAGING TO MITIGATE INTERMOLECULAR RECOMBINATION | Dec 18, 2022 | Pending |
Array
(
[id] => 18583240
[patent_doc_number] => 20230265500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => HIGH-COMPATIBILITY PCR-FREE LIBRARY CONSTRUCTION AND SEQUENCING METHOD
[patent_app_type] => utility
[patent_app_number] => 18/067540
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18067540
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/067540 | HIGH-COMPATIBILITY PCR-FREE LIBRARY CONSTRUCTION AND SEQUENCING METHOD | Dec 15, 2022 | Pending |
Array
(
[id] => 18552546
[patent_doc_number] => 20230250557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Protein scaffold
[patent_app_type] => utility
[patent_app_number] => 18/079887
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 371
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18079887
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/079887 | Protein scaffold | Dec 12, 2022 | Issued |
Array
(
[id] => 18879556
[patent_doc_number] => 20240002925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHODS, SYSTEMS AND KITS FOR POLYPEPTIDE PROCESSING AND ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 18/056970
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056970
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056970 | METHODS, SYSTEMS AND KITS FOR POLYPEPTIDE PROCESSING AND ANALYSIS | Nov 17, 2022 | Pending |
Array
(
[id] => 18628719
[patent_doc_number] => 20230287598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARY DETERMINING REGIONS
[patent_app_type] => utility
[patent_app_number] => 18/054045
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054045
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054045 | HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARY DETERMINING REGIONS | Nov 8, 2022 | Issued |
Array
(
[id] => 19158127
[patent_doc_number] => 20240150834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => PRIMER EXTENSION TARGET ENRICHMENT OF IMMUNE RECEPTOR SEQUENCES IN ALLOIMMUNE DISORDERS OF PREGNANCY
[patent_app_type] => utility
[patent_app_number] => 17/980393
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 303
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17980393
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/980393 | PRIMER EXTENSION TARGET ENRICHMENT OF IMMUNE RECEPTOR SEQUENCES IN ALLOIMMUNE DISORDERS OF PREGNANCY | Nov 2, 2022 | Pending |
Array
(
[id] => 19142492
[patent_doc_number] => 20240141332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => METHODS AND COMPOSITIONS FOR PREPARING NUCLEIC ACID LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 18/051966
[patent_app_country] => US
[patent_app_date] => 2022-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051966
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/051966 | METHODS AND COMPOSITIONS FOR PREPARING NUCLEIC ACID LIBRARIES | Nov 1, 2022 | Pending |
Array
(
[id] => 18305985
[patent_doc_number] => 20230109885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHODS FOR SCREENING VARIANT OF TARGET GENE
[patent_app_type] => utility
[patent_app_number] => 18/050476
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050476
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050476 | METHODS FOR SCREENING VARIANT OF TARGET GENE | Oct 27, 2022 | Pending |
Array
(
[id] => 18348312
[patent_doc_number] => 20230136423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => NUCLEASE-MEDIATED PLASMID INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 17/975844
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26538
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/975844 | NUCLEASE-MEDIATED PLASMID INTEGRATION | Oct 27, 2022 | Abandoned |